Crystal Research Enters into Strategic Partnership with MZ Group

Posted by Colleen Koski

May 22, 2013 at 9:33 AM

"We are very excited to partner with a great organization like Crystal Research. With fewer sell-side firms capable and willing to provide research coverage for small and microcap stocks, we see tremendous value in independent research. After seeing Jeff and his team work with a few of our clients, we were extremely impressed with their diligent process and comprehensive reports. Forming this partnership allows us to leverage our collective strengths to help investors fully understand our client's stories and to increase investor and media awareness and interest in our client's companies."

 

Read More

Topics: Crystal Research Associates, MZ Group

CEO Jeff Kraws Featured on Reuters' State of the Union Roundtable

Posted by Laura Swartz

February 13, 2013 at 3:14 PM

This morning, Crystal Research's CEO Jeff Kraws was invited to participate in a roundtable discussion to analyze how investors should be reacting to President Obama's State of the Union address. The segment was hosted by Thomson Reuters' Rhonda Schaffler and also featured David Joy, Chief Market Strategist of Ameriprise Financial, and Craig Irwin, Senior Vice President at Wedbush Securities.

Read More

Topics: Bridgelux, Crystal Research Associates, nanotechnology, green infrastructure, Unilife Corp., MetaStat

NEW INDUSTRY REPORT: Guide for Investing in Green Infrastructure

Posted by Laura Swartz

January 15, 2013 at 10:25 AM

Read More

Topics: Crystal Research Associates, nanotechnology, built environment, green infrastructure

Today, January 9, 2013 at 4 PM: "Fund Managers Unplugged"

Posted by Laura Swartz

January 9, 2013 at 9:43 AM

If you are at the OneMedForum conference in San Francisco today, we invite you to join us for the Special Session: Fund Managers Unplugged” panel occurring at 4 PM at the Sir Francis Drake Hotel.

Crystal Research Associates' CEO Jeffrey Kraws will be moderating the discussion, accompanied by panelists Mr. Dennis J. Purcell, Senior Managing Partner at Aisling Capital with approximately $1.7 billion in assets under management; Dr. J. Misha Petkevich, Co-founder of BladeRock Capital and former Chairman and CEO of The Petkevich Group, LLC; and Mr. William S. Slattery, Partner at Deerfield Management Company, L.P. where he focuses on biotechnology investments.

Read More

Topics: Crystal Research Associates, OneMedForum

"Special Session: Fund Managers Unplugged" at OneMedForum SF 2013

Posted by Laura Swartz

January 2, 2013 at 1:12 PM

CEO Jeff Kraws selected to moderate a Special Session "Fund Managers Unplugged" at the 6th Annual OneMedForum Conference in San Francisco on Wednesday, January 9, 2013.

Read More

Topics: Crystal Research Associates, OneMedForum

Happy Holidays from Crystal Research Associates

Posted by Laura Swartz

December 18, 2012 at 10:05 AM

Season's Greetings!

From all of us here at Crystal Research Associates, we would like to wish you and your family a joyful holiday season and a prosperous new year!

Read More

Topics: Crystal Research Associates, OneMedForum

Crystal Research Associates to Sponsor 6th Annual OneMedForum

Posted by Colleen Koski

October 16, 2012 at 12:22 PM

Partnership with OneMedPlace provides research and expanded media coverage to client companies

Read More

Topics: Crystal Research Associates, OneMedForum

New Nano Research: August 2012 Update Now Publicly Available

Posted by Laura Swartz

October 10, 2012 at 9:00 AM

Crystal Research Associates' August 2012 nanotechnology update is now available here. This report is part of our ongoing coverage to our initial comprehensive industry review, Nanotechnology and the Built Environment: The Transition to Green Infrastructure, published November 2011 and available at www.crystalra.com.

Read More

Topics: Crystal Research Associates, nanotechnology, built environment, green infrastructure

Monday's Small-cap Movers under Crystal Research's Coverage

Posted by Laura Swartz

August 6, 2012 at 5:04 PM

CNBC today published an article wherein the founder of Vanguard Group discussed his view on the necessity of investing in equities, which while higher risk, offer the potential for higher reward.

Read More

Topics: Crystal Research Associates, T3 Motion, Advaxis, Bioniche, Pluristem Therapeutics, Peregrine, Adamis

Syringe company Unilife Corp. (UNIS-NASDAQ) reports higher 4Q revenues

Posted by Laura Swartz

July 31, 2012 at 8:26 AM

Read More

Topics: Crystal Research Associates, Newsworthy Events, Unilife Corp., Prefilled Syringe

2Q Cleantech Investments of $1.6 billion Target Resource Efficiency

Posted by Laura Swartz

July 24, 2012 at 12:18 PM

Amid a depressed global economic environment, investments in cleantech were estimated to total $1.6 billion in the second quarter 2012, down from $1.9 billion in the first quarter 2012and $2.1 billion in the comparable year-ago period (second quarter 2011). Factors driving down investment include global economic uncertainties as well as political opposition to government subsidies in areas such as solar and wind power and electric vehicle development. A depressed U.S. IPO market is further hampering greentech funding efforts. 

Read More

Topics: Crystal Research Associates, nanotechnology, built environment, green infrastructure, Newsworthy Events, Soladigm

QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Receives Key Patent Allowance

Posted by Laura Swartz

July 16, 2012 at 4:27 PM

Novel biotech company AtheroNova Inc. (AHRO-OTC) made a significant news announcement last week when it reported the receipt of a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its main patent. The Notice of Allowance entailed written communication from the USPTO to AtheroNova that the Company’s primary patent was allowable. A Notice of Allowance specifies the amount of issue and/or publication fees that are due within three months in order to avoid abandonment of the applications (Source: USPTO). Accordingly, AtheroNova expects to announce the official patent issuance within the next few months once the registration process is complete.  

Read More

Topics: AtheroNova, Crystal Research Associates, Newsworthy Events, New Research

"Devices hurt by Obamacare, hospitals win: Kraws" (Replay and Transcript)

Posted by Laura Swartz

June 28, 2012 at 1:54 PM

This morning, Crystal Research CEO Jeff Kraws spoke with Reuters' Rhonda Schaffler about winners and losers of today's landmark Supreme Court ruling upholding Obamacare's individual mandate. Mr. Kraws discussed specific stocks to watch as well as sector trends for healthcare insurers, hospitals, pharma and biotech companies, medical records, medical schools, generics, and medical device companies, among others.

Read More

Topics: Crystal Research Associates, Newsworthy Events, Document Capture Technologies

"Beyond Wall Street's Panama Canal" Makes Case for Independent Research

Posted by Laura Swartz

May 21, 2012 at 11:32 AM

Crystal Research Associates' Director of Healthcare, David H. Talbot, discusses research trends in small-cap stocks on Seeking Alpha. Article excerpt below; click here for a link to the full text.

Read More

Topics: Crystal Research Associates, New Research

Sustainable Technologies Gain Momentum: New Report Highlights News

Posted by Laura Swartz

May 15, 2012 at 8:53 AM

As researchers have recently emphasized, governments have a significant role and responsibility for providing long-term support for renewable energy, smart grid, and other future “sustainable city” initiatives. The price of renewable energies and associated technologies are too high to appeal to investors without government support. Mechanisms such as incentives, feed‐in‐tariffs, tax‐breaks, rebates, and other financial instruments are critical.

With that in mind, we have released a 12-page report that expands upon several U.S. policies expected to further market adoption of sustainable, nanotechnology-driven technologies. The report, Continuing Coverage of Nanotechnology and the Built Environment (available here), is the latest update to our base report, Nanotechnology and the Built Environment: The Transition to Green Infrastructure. This update is part of a series of “continuing coverage” reports from Crystal Research Associates that detail innovations in nanotechnology and their impact on our infrastructure, building, and construction markets.

Read More

Topics: Crystal Research Associates, nanotechnology, built environment, green infrastructure

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic